Pfizer enters the obesity drug market with a reasonably valued deal, while valuation remains attractive and technicals show ...

Pfizer surged 15% last week on positive news, including a direct-to-consumer deal and a three-year tariff reprieve. Read why ...

Pfizer Inc on Tuesday updated its analysis of the safety profile of its COVID-19 vaccine seen during its large, late-stage trial, saying that 3.8% of participants experienced fatigue after receiving a ...

Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...

Pfizer (PFE) has seen its stock price move gradually higher over the past week, rising nearly 15% in that period. Investors ...

If you are watching Pfizer right now and feeling uncertain about whether to stay, buy, or even take profits, you are ...

Pfizer Inc is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters ...

US pharma major Pfizer (NYSE: PFE) has reported positive Phase III data that could help validate its $43 billion Seagen ...

Astellas Pharma (ALPMY) and Pfizer (PFE) announced positive results from the Phase 3 EV-303 clinical trial for PADCEV, a Nectin-4 directed ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the company announced a landmark agreement with the U.S. government aimed at lowering prescription ...

Pfizer Inc. (PFE) and Astellas Pharma U.S. Inc. announced final overall survival results from the Phase 3 EMBARK study evaluating XTANDI (enzalutamide), in combination ...

Pfizer has become the first Big Pharma company to strike a US drug pricing deal with the Trump administration.